Association between intestinal permeability and anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease

Inflammatory Bowel Diseases

Volumn 14, Issue 11, 2008, Pages 1610-1611

  Benjamin, Jaya ^a   Makharia, Govind K ^a   Joshi, Yogendra K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; LACTULOSE; MANNITOL;

ANTIBODY DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTESTINE MUCOSA PERMEABILITY; LETTER; PRIORITY JOURNAL; REFERENCE VALUE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; FEMALE; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY; PERMEABILITY; SACCHAROMYCES; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, FUNGAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LACTULOSE; MALE; MANNITOL; PERMEABILITY; REFERENCE VALUES; SACCHAROMYCES; SENSITIVITY AND SPECIFICITY;

EID: 59249086000     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20479     Document Type: Letter

References (8)

1. Makharia GK, Sachdev V, Gupta R, et al. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci. 2007;52: 33-39.
2. Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology. 1998;115:1006-1009.
3. Benjamin J, Makharia G K, Ahuja V, et al. Intestinal permeability and its association with the patients and disease characteristics in patients with Crohn's disease. World J Gastroenterol. 2008;14:1399-1405.
4. Stange EF, Travis SP, Vermeire S, et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55(Suppl 1):i1-15.
5. Barta Z, Csipo I, Szabo GG, et al. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol. 2003;9:2308-2312.
6. Hollander D. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg? Am J Gastroenterol. 2002;97:1867-1868.
7. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology. 2000;119:1740-1744.
8. Harrer M, Reinisch W, Dejaco C, et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease. Eur J Gastroenterol Hepatol. 2003;15:1281-1285.